IBRX (IBRX) Stock Price & Analysis
IBRX (IBRX) fell 1.34% to USD 8.08 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
IBRX last closed at USD 8.08; the session ranged USD 8.01–8.24 on volume of 4,330,218 shares. Market capitalization is —, with a 52-week range of USD 1.95–12.43 (NMS). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 8.08 |
|---|---|
| Change | ▼ 1.34% (down) |
| Previous Close | USD 8.08 |
| Open | USD 8.08 |
| Day Range | USD 8.01 – 8.24 |
| 52-Week Range | USD 1.95 – 12.43 |
| Volume | 4,330,218 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IBRX)
Nexqual's technical model rates IBRX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.8 (neutral) |
| vs SMA50 | Above (USD 7.88) |
| MACD | 0.13 (positive) |
From IBRX's Latest SEC 10-K Filing (filed 2026-02-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | USD 8.79 | ▲ 1.97% |
| SMMT | Summit Therapeutics Inc. | USD 17.61 | ▲ 20.58% |
| SLS | SELLAS Life Sciences Group, Inc | USD 13.86 | ▼ 2.12% |
| RXRX | Recursion Pharmaceuticals, Inc. | USD 3.63 | ▲ 7.4% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.